Quality of care in @entity1 with @entity2316 in Asia: The Joint Asia XXXX Evaluation (JADE) Registry.

@entity1 @entity286 @entity6 @entity2316 @entity16 @entity740 @entity633 @entity164 @entity989 @entity204 @entity65 @entity165
AIMS: @entity2316 independently predicts @entity65 and @entity204 . We examined the @entity740 ( @entity740 , defined as an estimated GFR <  60  ml/min/1.73  m(2) ) and quality of care in a cross-sectional survey of adults (age >=   18  years) with @entity164  2 @entity6 across Asia. METHODS: The Joint Asia @entity6 Evaluation programme is a disease-management programme implemented using an electronic portal that systematically captures clinical characteristics of all @entity1 enrolled. Between July 2007 and December 2012, data on 28  110 consecutively enrolled @entity1 (China: 3415, Hong Kong: 15  196, India: 3714, Korea: 1651, Philippines: 3364, Vietnam: 692, Taiwan: 78) were analysed. RESULTS: In this survey, 15.9% of @entity1 had @entity740 , 25.0% had microalbuminuria and 12.5% had macroalbuminuria. @entity1 with @entity740 were less likely to achieve HbA1c   <  53  mmol/mol (7.0%) (36.0% vs. 42.3%) and blood pressure <  130/80  mmHg (20.8% vs. 35.3%), and were more likely to have @entity989 (26.2% vs. 8.7%), @entity16 (29.0% vs. 7.7%), @entity65 (26.6% vs. 8.7%) and self-reported hypoglycaemia (18.9% vs. 8.2%). Despite high frequencies of @entity633 (74.8%) and dyslipidaemia (93.0%) among @entity740 @entity1 , only 49.0% were using renin-angiotensin system inhibitors and 53.6% were on statins. On logistic regression, old age, male gender, @entity286 use, long disease duration, high HbA1c , blood pressure and BMI, and low LDL @entity165 were independently associated with @entity740 (all P  <  0.05). CONCLUSIONS: The poor control of risk factors, suboptimal use of organ-protective drugs and high frequencies of hypoglycaemia highlight major treatment gaps in @entity1 with @entity2316 in Asia. This article is protected by copyright. All rights reserved.
